Nyse bdx.

The FDA determined that another recall of BD (NYSE:BDX) Alaris infusion pumps is Class I, the most serious kind. In the latest Alaris recall, the company cites compatibility issues with Cardinal Health Monoject syringes. The issue mainly relates to changes made to the products by Cardinal Health. It affects more than 1 million total …FRANKLIN LAKES, N.J., Dec. 9, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced publication of the results from a ...Jun 20, 2023 · DUBLIN, IRELAND , June 20, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase the ... Nov 10, 2023 · Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript November 9, 2023 Becton, Dickinson and Company reports earnings inline with expectations. Reported EPS is $3.42 EPS ...

FRANKLIN LAKES, N.J., Nov. 12, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth and depth of its core portfolio to fuel a new wave of growth through transformative solutions …April 16, 2021 By Sean Whooley. The FDA has identified another recall for the Alaris infusion pump from BD (NYSE:BDX) as Class I, the most serious kind of recall. BD’s latest recall, initiated on March 3, 2021, involves its BD Alaris infusion pump module system, which includes an infusion pump and vital signs monitoring system with a PC unit ...D.A. Davidson & CO. lifted its stake in shares of Becton, Dickinson and Company ( NYSE:BDX – Free Report) by 2.0% during the second quarter, according to its most recent filing with the ...

Jul 13, 2023 · Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ... Jun 20, 2023 · DUBLIN, IRELAND , June 20, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase the ...

FRANKLIN LAKES, N.J., Nov. 30, 2023 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, …Nov 24, 2023 · marketbeat.com - October 10 at 10:16 AM. Close Asset Management Ltd Has $169.95 Million Stake in Becton, Dickinson and Company (NYSE:BDX) marketbeat.com - October 9 at 1:37 PM. Investors in Becton Dickinson (NYSE:BDX) have seen returns of 20% over the past year. uk.style.yahoo.com - October 8 at 3:03 PM. FRANKLIN LAKES, N.J., May 16, 2023 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for the new BD Kiestra™ Methicillin-resistant Staphylococcus aureus (MRSA) imaging application that uses artificial ...Medical technology company Becton, Dickinson & Co (NYSE: BDX) saw shares plummet recently on weaker-than-expected guidance. The company expects revenues of between $20.1 billion and $20.3 billion ...

Nov 29, 2023 · The average twelve-month price prediction for Becton, Dickinson and Company is $283.86 with a high price target of $310.00 and a low price target of $260.00. Learn more on BDX's analyst rating history. Do Wall Street analysts like Becton, Dickinson and Company more than its competitors?

FRANKLIN LAKES, N.J., Dec. 8, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced the release of its second annual ...

Becton, Dickinson and Company (NYSE:BDX) is a multinational medical device company, headquartered in New Jersey, US. In January, BofA upgraded the stock to Buy with a $290 price target.FRANKLIN LAKES, N.J., Oct. 18, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new strategy to advance ...FRANKLIN LAKES, N.J., June 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced the worldwide commercial launch of a new ...Becton, Dickinson and Company (NYSE:BDX) reported adjusted earnings of $2.66 per share, up from $2.28 per share in the year-ago period. Revenue inched up 0.7 percent versus last year to $4.6 billion.Becton, Dickinson and Company last posted its earnings results on November 9th, 2023. The medical instruments supplier reported $3.42 earnings per share for the …

For context, this dividend growth streak is nine years longer than the next-best streaks by Becton, Dickinson (NYSE: BDX), AbbVie (NYSE: ABBV), and Abbott Laboratories (NYSE: ABT).NYSE: BDX. East Rutherford, New Jersey. $238.25 +2.07 (+0.88%) Share Price. as of December 1 4:00:00 PM EST. About Becton Dickinson. Becton, Dickinson & Co. is a medical technology company. The ...FRANKLIN LAKES, N.J., Aug. 11, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Christopher DelOrefice has ...Becton, Dickinson and Company (NYSE:BDX) reported adjusted earnings of $2.66 per share, up from $2.28 per share in the year-ago period. Revenue inched up 0.7 percent versus last year to $4.6 billion.Feb 19, 2023 · 12. Becton, Dickinson and Company (NYSE:BDX) Dividend Yield as of February 14: 1.50%. Number of Hedge Fund Holders: 52 Becton, Dickinson and Company (NYSE:BDX), also known simply as BD, is an ... FRANKLIN LAKES, N.J., June 12, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced the worldwide commercial launch of a new ...FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...

FRANKLIN LAKES, N.J., Feb. 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquartered in Salamanca, Spain, specializing in flow cytometry solutions for blood …Becton Dickinson and Co (NYSE:BDX) 235.80 Delayed Data As of Nov 29 +0.11 / +0.05% Today’s Change 228.62 Today ||| 52-Week Range 287.32 -7.27% Year-to-Date Quote Profile News Charts Forecasts...

Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ...Becton, Dickinson and Company (NYSE:BDX) Q1 2023 Earnings Call Transcript February 2, 2023 Operator: Hello, and welcome to BD’s First Fiscal Quarter of 2023 Earnings Call. At the request of BD ...Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased 6.8% to $5.1 billion as reported and rose 5.9% on a currency-neutral basisRevenue from the base business, which excludes COVID-only diagnostic testing, …14 Apr, 2021, 16:01 ET. FRANKLIN LAKES, N.J., April 14, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced it has ...GAAP and adjusted diluted EPS from continuing operations were $0.53 and $3.42, respectively. For the full fiscal year 2023, BDX's revenue reached $19.4 billion, marking a 2.7% increase as reported ...See the latest Becton Dickinson & Co stock price (BDX:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

FRANKLIN LAKES, N.J. and TUCSON, Ariz., Aug. 15, 2022 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in-vitro diagnostics in microbiology, today announced a worldwide commercial collaboration …

Find the latest Becton, Dickinson and Company (BDX) stock quote, history, news and other vital information to help you with your stock trading and investing.

NYSE Arca Telecommunications Index Today: Get all information on the NYSE Arca Telecommunications Index Index including historical chart, news and constituents. Indices Commodities Currencies StocksBecton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, …Get the latest Becton Dickinson and Co (BDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …The top 21 shareholders own 51% of the company. Insiders have been selling lately. A look at the shareholders of Becton, Dickinson and Company ( NYSE:BDX) can tell us which group is most powerful ...Reported EPS is $3.42 EPS, expectations were $3.42. Hello, and welcome to BD’s Fourth Quarter and Full Year Fiscal 2023 Earnings Call. At the request of BD, today’s call is being recorded and ...Price. %Change. BDX. 238.89. +0.88%. You can practice and explore trading BDX stock methods without spending real money on the virtual paper trading platform. Webull offers BDX Ent Holdg (BDX) historical stock prices, in-depth market analysis, NYSE: BDX real-time stock quote data, in-depth charts, free BDX options chain data, and a fully built .../PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023... BDX : 238.89 (+0.88%) Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028 FinancialNewsMedia - Tue Sep 26, 9:00AM CDTRead more on BDX stock here. Becton, Dickinson, and Company is a healthcare company with strong fundamentals and a history of dividend growth. ... (NYSE:BDX), which is part of the healthcare ...Becton, Dickinson and Company (NYSE:BDX) also raised its full-year profit forecast to between $12.10 and $12.32 from an initial target of between $12.07 and $12.32, signaling it is in the [ashes ...FRANKLIN LAKES, N.J., Jan. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it has been included in the ...BDX Put and Call Options List 1/17/2025 6/21/2024 3/15/2024 2/16/2024 1/19/2024 12/15/2023 Options Date Put and Call Options Put Options Call Options Options Type

14 Apr, 2021, 16:01 ET. FRANKLIN LAKES, N.J., April 14, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced it has ...Becton, Dickinson and Company (NYSE:BDX) is a New Jersey-based medical technology company that mainly specializes in the production of medical devices. In May, Barclays raised its price target on ...Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript November 9, 2023 Becton, Dickinson and Company reports earnings inline with expectations. Reported EPS is $3.42 EPS, expectations were $3.42. Operator: Hello, and welcome to BD’s Fourth Quarter and Full Year Fiscal 2023 Earnings Call. At the request …Nov 30, 2023 · The latest price target for . Becton Dickinson (NYSE: BDX) was reported by Piper Sandler on Friday, November 10, 2023.The analyst firm set a price target for 280.00 expecting BDX to rise to within ... Instagram:https://instagram. buys broken iphonesdecollteotcmkts remrfwhat is the future of silver Becton, Dickinson and Company has increased its dividend for the past 51 consecutive years. When did Becton, Dickinson and Company last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.04 on Thursday, November 9, 2023.Jul 13, 2023 · Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ... collector liquor bottlesday trading stock brokers FRANKLIN LAKES, N.J., Nov. 21, 2023 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and chief medical officer of BD, effective Dec. 4, 2023. Dr. Silverman will be …NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. This site is protected by reCAPTCHA and the Google Privacy ... floating rate etfs 10 сағат бұрын ... Becton, Dickinson and Company (NYSE:BDX - Get Free Report) had its target price cut by stock analysts at Morgan Stanley from $310.00 to ...Dec 4, 2023 · Polar Capital Holdings Plc bought a new stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 134,996 shares of the medical instruments supplier's stock, valued at appr